Clinical pharmacology and therapeutic use of antioxidant vitamins
Author
dc.contributor.author
Rodrigo Salinas, Ramón
Author
dc.contributor.author
Guichard, Cristián
Author
dc.contributor.author
Charles, Roberto
Admission date
dc.date.accessioned
2019-03-11T12:53:28Z
Available date
dc.date.available
2019-03-11T12:53:28Z
Publication date
dc.date.issued
2007
Cita de ítem
dc.identifier.citation
Fundamental and Clinical Pharmacology, Volumen 21, Issue 2, 2018, Pages 111-127
Identifier
dc.identifier.issn
07673981
Identifier
dc.identifier.issn
14728206
Identifier
dc.identifier.other
10.1111/j.1472-8206.2006.00466.x
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164306
Abstract
dc.description.abstract
The clinical use of antioxidants has gained considerable interest during the last decade. It was suggested from epidemiological studies that diets high in fruits and vegetables might help decrease the risk of cardiovascular disease. Therefore, supplements of vitamins C and E were applied through protocols aimed to prevent diseases such as atherosclerosis, preeclampsia or hypertension, thought to be mediated by oxidative stress. Despite the biological properties of these vitamins could account for an effective protection, as shown by several clinical and experimental studies, their efficacy remains controversial in the light of some recent clinical trials and meta-analyses. However, the methodology of these studies, criteria for selection of patients, the uncertain extent of progression of the disease when initiating supplementation, the lack of mechanistic studies containing basic scientific aspects, such as the bioavailability, pharmacokinetic properties, and the nature of the antioxi